Regulation of ATP-binding Cassette Transporters and Cholesterol Efflux by Glucose in Primary Human Monocytes and Murine Bone Marrow-derived Macrophages

 

 Buy Article Permissions and Reprints

Abstract

Purpose:

Individuals with type 2 diabetes mellitus are at increased risk of developing atherosclerosis. This may be partially attributable to suppression of macrophage ATP-binding cassette (ABC) transporter mediated cholesterol efflux by sustained elevated blood glucose concentrations. 2 models were used to assess this potential relationship: human monocytes/leukocytes and murine bone marrow-derived macrophages (BMDM).

Methods:

10 subjects (4 F/6 M, 50–85 years, BMI 25–35 kg/m²) underwent an oral glucose challenge. Baseline and 1- and 2-h post-challenge ABC-transporter mRNA expression was determined in monocytes, leukocytes and peripheral blood mononuclear cells (PBMC). In a separate study, murine-BMDM were exposed to 5 mmol/L D-glucose (control) or additional 20 mmol/L D- or L-glucose and 25 ug/mL oxidized low density lipoprotein (oxLDL). High density lipoprotein (HDL)-mediated cholesterol efflux and ABC-transporter (ABCA1 and ABCG1) expression were determined.

Results:

Baseline ABCA1and ABCG1 expression was lower (>50%) in human monocytes and PBMC than leukocytes (p<0.05). 1 h post-challenge leukocyte ABCA1 and ABCG1 expression increased by 37% and 30%, respectively (p<0.05), and began to return to baseline thereafter. There was no significant change in monocyte ABC-transporter expression. In murine BMDM, higher glucose concentrations suppressed HDL-mediated cholesterol efflux (10%; p<0.01) without significantly affecting ABCA1 and ABCG1 expression. Data demonstrate that leukocytes are not a reliable indicator of monocyte ABC-transporter expression.

Conclusions:

Human monocyte ABC-transporter gene expression was unresponsive to a glucose challenge. Correspondingly, in BMDM, hyperglycemia attenuated macrophage cholesterol efflux in the absence of altered ABC-transporter expression, suggesting that hyperglycemia, per se, suppresses cholesterol transporter activity. This glucose-related impairment in cholesterol efflux may potentially contribute to diabetes-associated atherosclerosis.

• References

• 1 Ryden L, Standl E, Bartnik M et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007; 28: 88-136
  CrossrefPubMedGoogle Scholar
• 2 Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. Jama 2002; 287: 2570-2581
  CrossrefPubMedGoogle Scholar
• 3 Park L, Wexler D. Update in diabetes and cardiovascular disease: synthesizing the evidence from recent trials of glycemic control to prevent cardiovascular disease. Curr Opin Lipidol 2010; 21: 8-14
  CrossrefPubMedGoogle Scholar
• 4 Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995; 15: 551-561
  CrossrefPubMedGoogle Scholar
• 5 Glass CK, Witztum JL. Atherosclerosis. the road ahead. Cell 2001; 104: 503-516
  CrossrefPubMedGoogle Scholar
• 6 Jessup W, Gelissen IC, Gaus K et al. Roles of ATP binding cassette transporters A1 and G1, scavenger receptor BI and membrane lipid domains in cholesterol export from macrophages. Curr Opin Lipidol 2006; 17: 247-257
  CrossrefPubMedGoogle Scholar
• 7 Wang X, Rader DJ. Molecular regulation of macrophage reverse cholesterol transport. Curr Opin Cardiol 2007; 22: 368-372
  CrossrefPubMedGoogle Scholar
• 8 Aiello RJ, Brees D, Bourassa PA et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002; 22: 630-637
  CrossrefPubMedGoogle Scholar
• 9 van Eck M, Bos IS, Kaminski WE et al. Leukocyte ABCA1 controls susceptibility to atherosclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA 2002; 99: 6298-6303
  CrossrefPubMedGoogle Scholar
• 10 van Eck M, Singaraja RR, Ye D et al. Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2006; 26: 929-934
  CrossrefPubMedGoogle Scholar
• 11 Bodzioch M, Orso E, Klucken J et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 1999; 22: 347-351
  CrossrefPubMedGoogle Scholar
• 12 Brooks-Wilson A, Marcil M, Clee SM et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 1999; 22: 336-345
  CrossrefPubMedGoogle Scholar
• 13 Rust S, Rosier M, Funke H et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 1999; 22: 352-355
  CrossrefPubMedGoogle Scholar
• 14 Passarelli M, Tang C, McDonald TO et al. Advanced glycation end product precursors impair ABCA1-dependent cholesterol removal from cells. Diabetes 2005; 54: 2198-2205
  CrossrefPubMedGoogle Scholar
• 15 Tang C, Kanter JE, Bornfeldt KE et al. Diabetes reduces the cholesterol exporter ABCA1 in mouse macrophages and kidneys. J Lipid Res 2010; 51: 1719-1728
  CrossrefPubMedGoogle Scholar
• 16 Mauldin JP, Srinivasan S, Mulya A et al. Reduction in ABCG1 in Type 2 diabetic mice increases macrophage foam cell formation. J Biol Chem 2006; 281: 21216-21224
  CrossrefPubMedGoogle Scholar
• 17 Mauldin JP, Nagelin MH, Wojcik AJ et al. Reduced expression of ATP-binding cassette transporter G1 increases cholesterol accumulation in macrophages of patients with type 2 diabetes mellitus. Circulation 2008; 117: 2785-2792
  CrossrefPubMedGoogle Scholar
• 18 Zhou H, Tan KC, Shiu SW et al. Determinants of leukocyte adenosine triphosphate-binding cassette transporter G1 gene expression in type 2 diabetes mellitus. Metabolism 2008; 57: 1135-1140
  CrossrefPubMedGoogle Scholar
• 19 Mauerer R, Ebert S, Langmann T. High glucose, unsaturated and saturated fatty acids differentially regulate expression of ATP-binding cassette transporters ABCA1 and ABCG1 in human macrophages. Exp Mol Med 2009; 41: 126-132
  CrossrefPubMedGoogle Scholar
• 20 Albrecht C, Simon-Vermot I, Elliott JI et al. Leukocyte ABCA1 gene expression is associated with fasting glucose concentration in normoglycemic men. Metabolism 2004; 53: 17-21
  CrossrefPubMedGoogle Scholar
• 21 Ghanbari-Niaki A, Saghebjoo M, Hedayati M. A single session of circuit-resistance exercise effects on human peripheral blood lymphocyte ABCA1 expression and plasma HDL-C level. Regul Pept 2011; 166: 42-47
  CrossrefPubMedGoogle Scholar
• 22 DiBlasio-Smith EA, Arai M, Quinet EM et al. Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells. J Transl Med 2008; 6: 1479-5876
  PubMedGoogle Scholar
• 23 Das SK, Gilhooly CH, Golden JK et al. Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. Am J Clin Nutr 2007; 85: 1023-1030
  PubMedGoogle Scholar
• 24 Nguyen MT, Favelyukis S, Nguyen AK et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279-35292
  CrossrefPubMedGoogle Scholar
• 25 Terpstra AH. Isolation of serum chylomicrons prior to density gradient ultracentrifugation of other serum lipoprotein classes. Anal Biochem 1985; 150: 221-227
  CrossrefPubMedGoogle Scholar
• 26 Schwartz DM, Wolins NE. A simple and rapid method to assay triacylglycerol in cells and tissues. J Lipid Res 2007; 48: 2514-2520
  CrossrefPubMedGoogle Scholar
• 27 Matthan NR, Giovanni A, Schaefer EJ et al. Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J Lipid Res 2003; 44: 800-806
  CrossrefPubMedGoogle Scholar
• 28 Meyer JM, Ji A, Cai L et al. High-capacity selective uptake of cholesteryl ester from native LDL during macrophage foam cell formation. J Lipid Res 2012; 53: 2081-2091
  CrossrefPubMedGoogle Scholar
• 29 Wang Y, Oram JF. Unsaturated fatty acids phosphorylate and destabilize ABCA1 through a protein kinase C delta pathway. J Lipid Res 2007; 48: 1062-1068
  CrossrefPubMedGoogle Scholar
• 30 Zhou H, Tan KC, Shiu SW et al. Cellular cholesterol efflux to serum is impaired in diabetic nephropathy. Diabetes Metab Res Rev 2008; 24: 617-623
  CrossrefPubMedGoogle Scholar
• 31 Zheng Z, Luo Y, McMaster GK. Sensitive and quantitative measurement of gene expression directly from a small amount of whole blood. Clin Chem 2006; 52: 1294-1302
  CrossrefPubMedGoogle Scholar
• 32 Feezor RJ, Baker HV, Mindrinos M et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 2004; 19: 247-254
  CrossrefPubMedGoogle Scholar
• 33 Uehara Y, Miura S, von Eckardstein A et al. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007; 191: 11-21
  CrossrefPubMedGoogle Scholar
• 34 Punyadeera C, van der Merwe MT, Crowther NJ et al. Weight-related differences in glucose metabolism and free fatty acid production in two South African population groups. Int J Obes Relat Metab Disord 2001; 25: 1196-1205
  CrossrefPubMedGoogle Scholar
• 35 Machado-Lima A, Iborra RT, Pinto RS et al. Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport. Diabetes Metab Res Rev 2013; 29: 66-76
  CrossrefPubMedGoogle Scholar